LINDSAY REMMLER: Open Payments
NPI 1932433935 · PORTAGE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 44 payments from 13 companies in 2025. Trend: 2023 $1,428 · 2024 $1,037 · 2025 $917
Food & beverage: $917
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $325 |
| GENZYME CORPORATION | 5 | $130 |
| Incyte Corporation | 5 | $120 |
| Janssen Biotech, Inc. | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $62 |
| Amgen Inc. | 2 | $34 |
| UCB, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| Organon LLC | 2 | $20 |
Products named: SKYRIZI, DUPIXENT, OPZELURA, RINVOQ, TREMFYA, COSENTYX, OTEZLA, Bimzelx.
Industry payments across MI — which companies pay providers there.
